These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 28275039)

  • 1. Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes.
    Lee MS; Menter DG; Kopetz S
    J Natl Compr Canc Netw; 2017 Mar; 15(3):411-419. PubMed ID: 28275039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left-Sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones.
    Tanaka J; Watanabe T; Kanazawa T; Tada T; Kazama Y; Tanaka T; Nagawa H
    J Surg Oncol; 2007 Dec; 96(7):611-8. PubMed ID: 17786961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.
    Messick CA; Kravochuck S; Church JM; Kalady MF
    Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancer.
    Tran CG; Goffredo P; Mott SL; Hart A; You YN; Vauthey JN; Weigel RJ; Hassan I
    Surgery; 2022 Mar; 171(3):657-665. PubMed ID: 34865865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
    Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
    Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
    Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS)].
    Wielandt AM; Villarroel C; Hurtado C; Simian D; Zamorano D; Martínez M; Castro M; Vial MT; Kronberg U; López-Kostner F
    Rev Med Chil; 2017 Apr; 145(4):419-430. PubMed ID: 28748988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
    Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
    Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype.
    Kwon Y; Park M; Jang M; Yun S; Kim WK; Kim S; Paik S; Lee HJ; Hong S; Kim TI; Min B; Kim H
    Oncotarget; 2017 Jun; 8(24):39367-39381. PubMed ID: 28455965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes.
    Loree JM; Pereira AAL; Lam M; Willauer AN; Raghav K; Dasari A; Morris VK; Advani S; Menter DG; Eng C; Shaw K; Broaddus R; Routbort MJ; Liu Y; Morris JS; Luthra R; Meric-Bernstam F; Overman MJ; Maru D; Kopetz S
    Clin Cancer Res; 2018 Mar; 24(5):1062-1072. PubMed ID: 29180604
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway.
    Bae JM; Kim JH; Kang GH
    Arch Pathol Lab Med; 2016 May; 140(5):406-12. PubMed ID: 27128298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression.
    Mukund K; Syulyukina N; Ramamoorthy S; Subramaniam S
    BMC Cancer; 2020 Apr; 20(1):317. PubMed ID: 32293332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.
    Bae JM; Kim JH; Kang GH
    Histol Histopathol; 2013 May; 28(5):585-95. PubMed ID: 23341177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
    Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
    Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway.
    Rhee YY; Kim KJ; Kang GH
    Gut Liver; 2017 Jan; 11(1):38-46. PubMed ID: 27885175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.
    Samowitz WS; Albertsen H; Sweeney C; Herrick J; Caan BJ; Anderson KE; Wolff RK; Slattery ML
    J Natl Cancer Inst; 2006 Dec; 98(23):1731-8. PubMed ID: 17148775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer.
    Huang CW; Tsai HL; Huang MY; Huang CM; Yeh YS; Ma CJ; Wang JY
    World J Surg Oncol; 2015 Aug; 13():257. PubMed ID: 26311139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Changing Spectrum of Colorectal Cancer Biology With Age: Implications for the Young Patient.
    Chouhan H; Ferrandon S; DeVecchio J; Kalady MF; Church JM
    Dis Colon Rectum; 2019 Jan; 62(1):21-26. PubMed ID: 30394984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.